Comments by WHO Europe director, Hans Kluge
The EMA provided an update on Tuesday this week , reiterating what Kluge said above that "the benefits of the AstraZeneca vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, outweigh the risks of side effects".
Search Web: WHO Europe director: The benefits of AstraZeneca vaccine outweigh any risks
Recent Posts
- S&P 500 Holds Losses Despite Pullback in Short-Term Consumer Inflation Expectations
- Gold Price Forecast: Gold Threatens Larger Break, 1854 Support in Sight
- Markets Week Ahead: Dow Jones, US Dollar, Gold, Euro, Fed, CPI, China
- S&P 500 Outlook: Equities Drop Ahead of Peloton, Disney and Alibaba Earnings
- USD/JPY Forecast – Setting Up for the Next Leg Higher?
ZH-CN
EN
FR
DE
ES